Indian pharma industry to witness 8-10% revenue growth in fiscal 2024: CRISIL
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.
India will account for about 18% of the Asia-Pacific (APAC) MRI systems market in 2023
Eris Lifesciences enters into term loan agreement with Citi Bank
With India supplying around 60% of the world's vaccine needs and 20-22% of generic exports, the country is dedicated to providing affordable, high-quality drugs and contribute to global accessibility
The medical device sector is considered as one of the sunrise sectors in the country
The company has secured 506 marketing approvals for its oncology products across 76 countries.
Unfortunate to see PM’s ‘Make in India’ dream being bulldozed
Granules India sponsored an initiative to ignite a drug-free revolution and contribute towards an empowered society
Subscribe To Our Newsletter & Stay Updated